Pericardiectomy is performed for a wide variety of pericardial diseases including relapsing pericarditis, effusive-constrictive pericarditis, and chronic constriction. In each of these conditions, we prefer complete pericardiectomy with removal of the anterior and diaphragmatic pericardium. Tricuspid regurgitation (TR) and radiation-induced disease present special challenges. Surgical outcomes depend on the underlying pathology, degree of preoperative disability, and associated cardiac and systemic diseases.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Canadian Journal of Cardiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Pericardiectomy vs medical management in patients with relapsing pericarditis.Mayo Clin Proc. 2012; 87: 1062-1070https://doi.org/10.1016/j.mayocp.2012.05.024
Calderon-Rojas R, Schaff HV. Pericardial Diseases. In: Raja SG, ed. Cardiac Surgery: A Complete Guide. Springer International Publishing; 2020:703-716. doi:10.1007/978-3-030-24174-2_77
- Surgical management of effusive pericardial disease. Influence of extent of pericardial resection on clinical course.J Thorac Cardiovasc Surg. 1985; 90: 506-516https://doi.org/10.1016/S0022-5223(19)38563-0
- Experience With Pericardiectomy for Constrictive Pericarditis Over Eight Decades.Ann Thorac Surg. 2017; 104: 742-750https://doi.org/10.1016/j.athoracsur.2017.05.063
- Tricuspid Valve Regurgitation in Patients Undergoing Pericardiectomy for Constrictive Pericarditis.Semin Thorac Cardiovasc Surg. 2020; 32: 721-728https://doi.org/10.1053/j.semtcvs.2020.03.003
Accepted: January 30, 2023
Received in revised form: January 27, 2023
Received: December 15, 2022
Publication stageIn Press Journal Pre-Proof
Funding: None to declare.
Disclosures: None to declare.
© 2023 Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.